ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,112.65
0.25%
US Tech 100
17,299.80
0.35%
다우존스 지수
38,356.09
0.30%
Bitcoin
62,892.05
-0.17%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Vir Biotechnology Inc (VIR)

  7. Vir Biotechnology Inc (VIR) 뉴스

VIR Vir Biotechnology Inc

8.41
0.18 (2.19%)
최종 업데이트: 01:53:55
15분 지연
기업명 주식 심볼 시장 주식 타입
Vir Biotechnology Inc VIR 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.18 2.19% 8.41 01:53:55
개장가 저가 고가 종가 전일 종가
8.31 8.25 8.50 8.23
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
18/04/202421:00BWVir Biotechnology Announces Nomination of Norbert..
12/04/202405:30BWVir Biotechnology to Provide Business Update and Report..
05/03/202422:05BWVir Biotechnology Completes Enrollment of Phase 2 Chronic..
27/02/202409:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202409:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202409:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202409:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202406:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/02/202406:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/02/202422:05BWVir Biotechnology to Participate in Upcoming Investor..
23/02/202406:12EDGAR2Form 8-K - Current report
23/02/202406:05BWVir Biotechnology Provides Corporate Update and Reports..
21/02/202406:33EDGAR2Form 8-K - Current report
21/02/202406:30BWVir Biotechnology Announces Dr. Phil Pang Will Step Down as..
17/02/202408:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202407:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/02/202406:05BWVir Biotechnology to Provide Business Update and Report..
04/01/202404:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202319:59IHMARKETNEWSApple Stocks Reach Record, Adobe Faces Stock Drops,..
14/12/202306:06EDGAR2Form 8-K - Current report
14/12/202306:05BWVir Biotechnology Announces Strategic Steps to Reduce..
07/12/202306:05BWVir Biotechnology to Present at J.P. Morgan 2024 42nd Annual..
13/11/202322:00BWVir Biotechnology to Present New Data from Its Ongoing Phase..
10/11/202322:00BWVir Biotechnology to Present Late-Breaking Data from Its..
08/11/202322:05BWVir Biotechnology Ranked the Fastest-Growing Company in..
04/11/202305:37EDGAR2Form 8-K - Current report
04/11/202305:33EDGAR2Form S-3ASR - Automatic shelf registration statement of..
04/11/202305:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202305:09EDGAR2Form 8-K - Current report
03/11/202305:05BWVir Biotechnology Provides Corporate Update and Reports..
30/10/202321:00BWVir Biotechnology Appoints Jennifer Towne, Ph.D., as..
13/10/202305:05GLOBEVir Biotechnology to Participate in the H.C. Wainwright 4th..
11/10/202321:00GLOBEVir Biotechnology Announces Multiple Abstracts Highlighting..
06/10/202305:30GLOBEVir Biotechnology to Provide Business Update and Report..
03/10/202321:01EDGAR2Form 8-K - Current report
03/10/202320:59GLOBEVir Biotechnology Awarded BARDA Funding to Support..
20/09/202321:00GLOBEVir Biotechnology Announces First Participant Dosed in New..
20/09/202319:02EDGAR2Form 8-K - Current report
30/08/202305:30GLOBEVir Biotechnology to Participate in Upcoming Investor..
05/08/202305:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202305:14EDGAR2Form 8-K - Current report
04/08/202305:05GLOBEVir Biotechnology Provides Corporate Update and Reports..
27/07/202305:05GLOBEVir Biotechnology to Provide Business Update and Report..
20/07/202321:04EDGAR2Form 8-K - Current report
20/07/202321:00GLOBEVir Biotechnology Announces Topline Data from Phase 2..
06/07/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/07/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/06/202306:01EDGAR2Form 144 - Report of proposed sale of securities
29/06/202322:00GLOBEVir Biotechnology Appoints Sasha Damouni Ellis as Executive..
24/06/202318:30GLOBEVir Biotechnology Presents New Data Evaluating the Potential..

최근 히스토리

NASDAQ
VIR
Vir Biotechnology
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유